Company: STAA
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284603
Chunk: 9

Company: STAAR SURGICAL CO
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 9
---
 independent public company, STAAR common stock will continue to be listed and traded on NASDAQ and registered under the 
 Exchange Act, and STAAR will continue to file periodic and other reports with the SEC.                                                                                                                                                                |

8

Under specified circumstances, upon termination of the Merger Agreement, STAAR will be required to pay Alcon a termination fee of up to $43,425,000 in cash, or Alcon will be required to pay STAAR a termination fee of $72,375,000 in cash, as described in “ The Merger Agreement—Termination Fees.” Pursuant to the Amendment, the termination fee payable by STAAR to Alcon has been reduced to $0 in certain circumstances, including if STAAR terminates the Merger Agreement to accept a Superior Offer from a Qualified Bidder, as described in the “ The Merger Agreement—Amendment .” (3) Supplements to “Special Note Regarding Forward-Looking Statements” The section titled “Special Note Regarding Forward-Looking Statements” beginning on page 21 of the proxy statement is hereby amended and supplemented to add the following additional risk factor:

| • |     | the possibility that no alternative proposals will be received during                                                                    
 the go-shop period, or that any such alternative proposals are not determined by the Company’s board to be superior to the Alcon merger; |

(4) Supplements to “Risk Factors” The first and fifth paragraphs of the risk factor that begins with the heading, “The consummation of the Merger is subject to certain closing conditions…” on pages 23-24 ofthe proxy statement are hereby amended and supplemented as follows: The obligations of STAAR, Alcon and Merger Sub to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction or waiver of a number of conditions, including the adoption of the Merger Agreement by holders of a majority of the outstanding shares of STAAR common stock entitled to vote thereon. Ownership of STAAR common stock is currently concentrated among a few stockholders, and STAAR’s largest stockholder, Broadwood Partners, L.P. (“Broadwood”), reported beneficial ownership as of August 8, 2025 of approximately 27.3 27.4% of STAAR’s outstanding shares of STAAR common stock. On September 2, 2025, Broadwood filed a Schedule 13D/A and issued a related press release indicating, among other things, that it intends to vote against the Merger Proposal. On September 24,